194 related articles for article (PubMed ID: 24820737)
1. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden.
Thorvaldsen T; Benson L; Hagerman I; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2014 Jul; 175(1):55-61. PubMed ID: 24820737
[TBL] [Abstract][Full Text] [Related]
2. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Pölzl G; Altenberger J; Baholli L; Beltrán P; Borbély A; Comin-Colet J; Delgado JF; Fedele F; Fontana A; Fruhwald F; Giamouzis G; Giannakoulas G; Garcia-González MJ; Gustafsson F; Kaikkonen K; Kivikko M; Kubica J; von Lewinski D; Löfman I; Malfatto G; Manito N; Martínez-Sellés M; Masip J; Merkely B; Morandi F; Mølgaard H; Oliva F; Pantev E; Papp Z; Perna GP; Pfister R; Piazza V; Bover R; Rangel-Sousa D; Recio-Mayoral A; Reinecke A; Rieth A; Sarapohja T; Schmidt G; Seidel M; Störk S; Vrtovec B; Wikström G; Yerly P; Pollesello P
Int J Cardiol; 2017 Sep; 243():389-395. PubMed ID: 28571618
[TBL] [Abstract][Full Text] [Related]
3. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.
Parle NM; Thomas MD; Dembo L; Best M; Driscoll GO
Heart Lung Circ; 2008 Jun; 17(3):206-10. PubMed ID: 18242130
[TBL] [Abstract][Full Text] [Related]
4. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?
Palmerini E; Söderberg S; Mondillo S; Favilli R; Lunghetti S
Acute Card Care; 2015 Mar; 17(1):14-9. PubMed ID: 25806830
[TBL] [Abstract][Full Text] [Related]
5. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
Tasal A; Erturk M; Uyarel H; Karakurt H; Bacaksiz A; Vatankulu MA; Turfan M; Sonmez O; Erdogan E; Ergelen M
J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
7. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
Silvetti S; Nieminen MS
Int J Cardiol; 2016 Jan; 202():138-43. PubMed ID: 26386941
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan: a retrospective single-center case series.
Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan produces an additional clinical and hemodynamic benefit in patients with decompensated heart failure successfully submitted to a fluid removal treatment.
Giglioli C; Cecchi E; Landi D; Chiostri M; Spini V; Valente S; Gensini GF; Romano SM
Congest Heart Fail; 2012; 18(1):47-53. PubMed ID: 22277178
[TBL] [Abstract][Full Text] [Related]
10. The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study.
Rossinen J; Harjola VP; Siirila-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS
Acute Card Care; 2008; 10(4):209-13. PubMed ID: 18720087
[TBL] [Abstract][Full Text] [Related]
11. The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies.
Lilleberg J; Ylönen V; Lehtonen L; Toivonen L
Scand Cardiovasc J; 2004 May; 38(2):80-4. PubMed ID: 15204232
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of levosimendan in patients with acute heart failure.
Fedele F; D'Ambrosi A; Bruno N; Caira C; Brasolin B; Mancone M
J Cardiovasc Pharmacol; 2011 Oct; 58(4):363-6. PubMed ID: 21697728
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
Lahtinen P; Pitkänen O; Pölönen P; Turpeinen A; Kiviniemi V; Uusaro A
Crit Care Med; 2011 Oct; 39(10):2263-70. PubMed ID: 21666445
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
Mebazaa A; Erhardt L
Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347
[TBL] [Abstract][Full Text] [Related]
15. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
Yontar OC; Yilmaz MB; Yalta K; Tandoğan I
Anadolu Kardiyol Derg; 2010 Aug; 10(4):310-6. PubMed ID: 20693125
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
[TBL] [Abstract][Full Text] [Related]
18. Facilitation of left ventricular function recovery post percutaneous coronary intervention by levosimendan.
Qarawani D; Cohen A; Nahir M; Hasin Y
Int J Cardiol; 2013 Sep; 168(1):237-42. PubMed ID: 23063476
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction.
Jia Z; Guo M; Zhang YQ; Liang HQ; Zhang LY; Song Y
Cardiology; 2014; 128(2):195-201. PubMed ID: 24751462
[TBL] [Abstract][Full Text] [Related]
20. Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period.
Papadopoulou EF; Mavrogeni SI; Dritsas A; Cokkinos DV
Hellenic J Cardiol; 2009; 50(4):269-74. PubMed ID: 19622496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]